| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/05/2004 | US20040020265 3D array of integrated cells for the sampling and detection of air bound chemical and biological species |
| 02/05/2004 | US20040020263 Sock testing method and apparatus for performing the same |
| 02/05/2004 | DE19706486B4 Sensoreinrichtung zum Bestimmen des Alterungszustands flüssiger Medien Sensor means for determining the aging state of liquid media |
| 02/05/2004 | DE10251872B3 Water hardness control sensor device for domestic purposes, has sensor unit for acquiring a parameter, especially for controlling water hardening, and a unit for precipitating out dissolved lime in water sample |
| 02/05/2004 | DE10240410B3 Determining oxygen requirement of aqueous solution, especially effluent, in clarifying process comprises digesting sample of aqueous solution by burning, and removing salts obtained in sample |
| 02/05/2004 | DE10234161A1 Device for feeding gas to sensor used as filter for removing particles from gas stream fed to sensor comprises gas line having gas inlet opening covered with protection unit |
| 02/05/2004 | DE10233087A1 Reflexionsphotometrisches Analysesystem Reflection Photometric Analysis System |
| 02/05/2004 | DE10232695A1 Immobilisierungsschicht für Biosensoren Immobilization for biosensors |
| 02/05/2004 | DE10231753A1 Specific-affinity biosensor for determining binding properties of proteins, comprises a surface prepared by binding solid phase reagents and interceptor molecules to it |
| 02/05/2004 | DE10230141A1 Verfahren zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc) Method for the enrichment and detection of altered prion protein (PrPSc) |
| 02/05/2004 | DE10150009B4 Verfahren zur Bestimmung der Destillationscharakteristik von flüssigen Erdölprodukten über eine Schnelldestillation im kleinen Maßstab und Verwendung einer Vorrichtung zum Einsatz des Verfahrens A method for determining the distillation characteristics of liquid petroleum products through a flash distillation on a small scale and using a device for use of the method |
| 02/05/2004 | DE10134885B4 Modulares Analysesystem Modular analysis system |
| 02/05/2004 | DE10109901B4 Verfahren zum Nachweis von TSE-induzierten Veränderungen in menschlichen und tierischen Körperflüssigkeiten A method of detecting TSE-induced changes in the human and animal body fluids |
| 02/05/2004 | CA2790024A1 Methods and reagents for improved selection of biological materials |
| 02/05/2004 | CA2727782A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2533670A1 Method system and devices for converting venous blood values to arterial blood values |
| 02/05/2004 | CA2531779A1 Multi-reporter gene model for toxicological screening |
| 02/05/2004 | CA2494929A1 Sampling device |
| 02/05/2004 | CA2494793A1 Novel serine protease |
| 02/05/2004 | CA2494715A1 Method for automated, large-scale measurement of the molecular flux rates using mass spectrometry |
| 02/05/2004 | CA2493798A1 Improved systems and methods for analysis of protein post-translational modification |
| 02/05/2004 | CA2493676A1 Methods for perfusion and plating of primary hepatocytes and a medium therefore |
| 02/05/2004 | CA2493671A1 Lipophilic electrophoretic probes |
| 02/05/2004 | CA2493636A1 Methods and apparatus for the measurement of hydrogen sulphide and thiols in fluids |
| 02/05/2004 | CA2493613A1 Method for analyzing readings of nucleic acid assays |
| 02/05/2004 | CA2493608A1 Method and apparatus for control of mobility-based ion species identification |
| 02/05/2004 | CA2493314A1 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
| 02/05/2004 | CA2493309A1 Site-specific labelling of proteins using cyanine dye reporters |
| 02/05/2004 | CA2493306A1 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | CA2493264A1 New method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht2c receptor |
| 02/05/2004 | CA2492933A1 Method and device for screening molecules in cells |
| 02/05/2004 | CA2492463A1 Regulated aptamer therapeutics |
| 02/05/2004 | CA2492444A1 Modified adamts4 molecules and method of use thereof |
| 02/05/2004 | CA2492333A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | CA2486283A1 Methods for fragmentation, labeling and immobilization of nucleic acids |
| 02/04/2004 | EP1387390A2 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 02/04/2004 | EP1387173A1 Method for improved diagnosis of cervical lesions based on detection of INK4a gene products |
| 02/04/2004 | EP1387172A2 Bovine viral diarrhea virus serum antigen capture immunoassay |
| 02/04/2004 | EP1387171A1 Analyzers and methods of analyzing blood |
| 02/04/2004 | EP1387170A1 Specimen analyzing implement |
| 02/04/2004 | EP1387169A1 Method of attaching hydrophilic species to hydrophilic macromolecules and immobilizing the hydrophilic macromolecules on a hydrophobic surface |
| 02/04/2004 | EP1387168A2 Physiologically active substance-measuring reagent and method for measuring physiologically active substance |
| 02/04/2004 | EP1387167A1 Method for identifying biologically active compounds with anti-asthmatic, anti-allergic and/or immunosuppresive properties |
| 02/04/2004 | EP1387165A1 Method and device for monitoring the quality of lubricants using ion mobility spectroscopy |
| 02/04/2004 | EP1386968A1 Gene expression controlling unit and utilization thereof |
| 02/04/2004 | EP1386967A2 DNA Encoding Mammalian phosphodiesterases |
| 02/04/2004 | EP1386965A1 Novel potential-dependent cation channel protein |
| 02/04/2004 | EP1386963A1 Peptides having cytotoxicity inhibitory activity and method of screening these peptides having cytotoxicity inhibitory activity |
| 02/04/2004 | EP1386946A1 4,7-dichlororhodamine dyes useful as molecular probes |
| 02/04/2004 | EP1386933A1 Cytokine antagonists and agonists |
| 02/04/2004 | EP1386931A1 Human neurotrimin homologue |
| 02/04/2004 | EP1386927A1 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors |
| 02/04/2004 | EP1386660A1 Isolation of proteins |
| 02/04/2004 | EP1386617A1 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents |
| 02/04/2004 | EP1386615A1 EG-VEGF/Prokineticin 2 receptor antagonists |
| 02/04/2004 | EP1386343A1 A microfluidic system (edi) |
| 02/04/2004 | EP1386279A2 Method for inhibiting metap2 |
| 02/04/2004 | EP1386275A2 A process for discriminating between biological states based on hidden patterns from biological data |
| 02/04/2004 | EP1386274A2 Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal |
| 02/04/2004 | EP1386264A2 System for cellular storage and genetic information retrieval |
| 02/04/2004 | EP1386169A1 Three-dimensional microfluidics incorporating passive fluid control structures |
| 02/04/2004 | EP1386167A2 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 02/04/2004 | EP1386166A2 Anti-epileptogenic agents |
| 02/04/2004 | EP1386165A2 Inflammatory markers for detection and prevention of diabetes mellitus |
| 02/04/2004 | EP1386164A2 Differential immunoassay |
| 02/04/2004 | EP1386163A2 Isolated ductal fluid sample |
| 02/04/2004 | EP1386162A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 02/04/2004 | EP1386160A2 Method for detecting blood cell antigens and the antibodies in response to the same |
| 02/04/2004 | EP1386159A2 Use of high density microparticles for removal of pathogens |
| 02/04/2004 | EP1386158A1 Object comprising an uncharged, functionalized hydrogel surface |
| 02/04/2004 | EP1386157A2 Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors |
| 02/04/2004 | EP1386156A2 Individualization of therapy with antineoplastic agents |
| 02/04/2004 | EP1386155A2 Therapeutic and diagnostic uses of antibody specificity profiles |
| 02/04/2004 | EP1386154A1 Automated methods of detecting receptor activity |
| 02/04/2004 | EP1386153A2 Oxazolidinone photoaffinity probes, uses and compounds |
| 02/04/2004 | EP1386152A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
| 02/04/2004 | EP1386151A2 Method and device for determining a characteristic value that is representative of the condition of a gas |
| 02/04/2004 | EP1386150A1 Insect ammunition vectors and methods of use to identify pesticide targets |
| 02/04/2004 | EP1386147A2 A method of measuring the concentration of hydrogen and methane in nitrogen by means of ion mobility spectrometry |
| 02/04/2004 | EP1386146A2 A method for measuring the total concentration of carbon monoxide and hydrocarbons in oxygen by means of ion mobility spectrometry |
| 02/04/2004 | EP1386007A2 Skin treatment |
| 02/04/2004 | EP1386002A1 Methods and compositions for nucleotide analysis |
| 02/04/2004 | EP1386000A2 Method and device for determining and selecting molecule-molecule interactions |
| 02/04/2004 | EP1385999A2 Reagents and methods for automated in situ or microarray hybridization |
| 02/04/2004 | EP1385998A1 Biomolecule characterization using mass spectrometry and affinity tags |
| 02/04/2004 | EP1385996A2 Charge tags and separation of nucleic acid molecules |
| 02/04/2004 | EP1385995A2 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 02/04/2004 | EP1385994A2 Method for specifically detecting, isolating and characterizing cells from body samples by transfecting nucleic acid constructs |
| 02/04/2004 | EP1385993A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 02/04/2004 | EP1385992A2 Cancer associated protein kinases and their uses |
| 02/04/2004 | EP1385990A1 Methods and kits utilizing heparanase as a diagnostic marker for haemostatic disorders |
| 02/04/2004 | EP1385989A2 Il-1 inhibition for myeloma and related disorders |
| 02/04/2004 | EP1385988A2 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications |
| 02/04/2004 | EP1385986A2 Biochip arrangement |
| 02/04/2004 | EP1385983A1 In vivo methods of determining activity of receptor-type kinase inhibitors |
| 02/04/2004 | EP1385982A2 Methods and means for detecting enzymatic cleavage and linkage reactions |
| 02/04/2004 | EP1385981A2 Antifungal compounds and methods of use |
| 02/04/2004 | EP1385978A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding these human drug-metabolizing proteins, and uses thereof |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385957A1 Functions for d52 and ra006 nucleic acids and polypeptides |